樱桃视频

September 30, 2016

Doctors don't communicate well about terminally ill patients

Cancer specialists and primary care physicians are not communicating very well about the end-of-life concerns of the patients they share - and according to one new study, they often rely on those patients to convey information back and forth.

September 27, 2016

Cancer patients may be overly optimistic about early drug trial participation

People with cancer may overestimate the possible benefits to them of participating in an early trial of a new medicine, even after talking with a doctor about what to expect, according to a new study from the U.K. So-called phase 1 trials of experimental treatments are intended to test the drug's safety.

September 22, 2016

Vasectomies not linked to increased prostate cancer risk

Having a vasectomy doesn't increase a man's risk of developing prostate cancer or dying from it, a U.S. study suggests.

September 19, 2016

Cancer-risk genetic testing reports can vary from lab to lab

Testing for gene mutations linked to cancer risk may guide how a patient is treated, but the determination of whether a mutation is dangerous or benign can vary from lab to lab, according to a recent study.

September 15, 2016

Too soon to tell if 9/11 firefighters face increased cancer risk, study says

Fifteen years after the 9/11 attacks, the jury is still out on whether firefighters who worked at the World Trade Center site have increased odds of developing cancer, a U.S. study suggests.

September 15, 2016

Treat or monitor early prostate cancer? 10-year survival is the same, study says

Men with early prostate cancer who choose to closely monitor their disease are just as likely to survive at least 10 years as those who have surgery or radiation, finds a major study that directly tested and compared these options.

August 23, 2016

Pfizer boosts cancer drug roster with $14B Medivation deal

Pfizer Inc, beating out numerous other bidders, said it would buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.

July 26, 2016

American Cancer Society disputes study on rising prostate cancer cases

The American Cancer Society is disputing results from a study publicized last week by Northwestern University researchers that suggested a sharp rise in the number of deadly, metastatic prostate cancer cases.

July 19, 2016

Metastatic prostate cancer cases rising, study finds

The number of deadly metastatic prostate cancer cases increased considerably in the last decade, potentially due to a recent decrease in the number of men screened for disease, according to a new study.

July 14, 2016

Antipsychotic drug also relieves nausea from cancer chemotherapy

Adding the cheap antipsychotic drug olanzapine to conventional anti-vomiting medicine can help prevent nausea in cancer patients, according to a new test of 380 volunteers.